Designing Peptide-Based Nanoinhibitors of Programmed Cell Death Ligand 1 (PD-L1) for Enhanced Chemo-immunotherapy
ACS Nano · 2024
DOI: 10.1021/acsnano.3c09968 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Fengjuan Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200241, People's Republic of China. Hauptthemen laut MEDLINE: B7-H1 Antigen, Immunotherapy. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, Natural Science Foundation of Chongqing Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200241, People's Republic of China.
- Department of Breast Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, People's Republic of China.
- School of Medicine, Shanghai University, Shanghai 200444, People's Republic of China.
- Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, People's Republic of China.
- Department of Clinical Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, People's Republic of China.
ORCID-Profile: Meiyan Wang, Jingjing Wan
Förderung
- Natural Science Foundation of Shanghai Municipality
- Natural Science Foundation of Chongqing Municipality
- National Natural Science Foundation of China
- State Key Laboratory of Oncogenes and Related Genes
Zitieren
APA
Xie, F., Tang, S., Zhang, Y., Zhao, Y., Lin, Y., Yao, Y., Wang, M., Gu, Z., & Wan, J. (2024). Designing Peptide-Based Nanoinhibitors of Programmed Cell Death Ligand 1 (PD-L1) for Enhanced Chemo-immunotherapy. ACS Nano. https://doi.org/10.1021/acsnano.3c09968
Vancouver
Xie F, Tang S, Zhang Y, Zhao Y, Lin Y, Yao Y, et al. Designing Peptide-Based Nanoinhibitors of Programmed Cell Death Ligand 1 (PD-L1) for Enhanced Chemo-immunotherapy. ACS Nano. 2024. doi:10.1021/acsnano.3c09968
BibTeX
@article{Xie2024,
author = {Xie, Fengjuan and Tang, Shasha and Zhang, Ye and Zhao, Yinbing and Lin, Yingying and Yao, Yining and Wang, Meiyan and Gu, Zhengying and Wan, Jingjing},
title = {Designing Peptide-Based Nanoinhibitors of Programmed Cell Death Ligand 1 (PD-L1) for Enhanced Chemo-immunotherapy},
journal = {ACS Nano},
year = {2024},
doi = {10.1021/acsnano.3c09968}
}
EUVIMED